Diane Diehl talks about how she has gained marketing, business development, and operations skills while leading scientific teams throughout her career.
The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease brings together Danish and ӳý scientists. Managing director Kasper Lage shares the center’s origin story, its achievements so far, and what the future holds.
Scientists have engineered an adeno-associated virus (AAV) that efficiently crosses the blood-brain barrier in human cell models and delivers genes throughout the brain in humanized mice.
Tightly synchronized genetic changes in two types of brain cells may underlie cognitive impairment in both conditions, offering potential therapeutic clues.
Ralda Nehme, director of ӳý’s stem cell program, talks about how stem cells can be a model for disease in a dish and what scientists can learn from these experiments.
A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.
Scientists from the US and West Africa have teamed up to build a better public health network that can quickly detect and respond to emerging viral threats.
In a pilot study with patient samples, the technology performed as well as the current gold-standard methods, yielding accurate results within hours instead of days.
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.
A single-cell analysis of 3D models of the human cerebral cortex suggests they can be used to study important brain processes that have been difficult to investigate.
New method finds compounds that bind and inhibit individual members of a family of key regulatory proteins, called cyclophilins, that have been difficult to target selectively.
The new Leiomyosarcoma Project joins an existing effort, Count Me In’s Osteosarcoma Project, to partner with patients and accelerate scientific discovery in rare cancers.
Addition of six-story facility will bring ӳý’s footprint in Kendall to nearly one million square feet, significantly increasing lab space for scientific innovation